Marshall Wace’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Marshall Wace’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115,496	Closed	-$5.37M	–	2864
2023 Q2	$5.37M	Buy	+115,496	New	+$3.99M	0.01%	991
2022 Q1	–	Sell	-42,500	Closed	-$1.08M	–	4254
2021 Q4	$1.08M	Hold	42,500	–	–	﹤0.01%	2441
2021 Q3	$1.39M	Buy	+42,500	New	+$1.45M	0.01%	1798

Marshall Wace's DICE Position: Q3 2023 in Review

Marshall Wace sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 115,496 shares — an estimated $5.37M sold.

Marshall Wace first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $5.37M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Marshall Wace reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Marshall Wace sold 115,496 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $5.37M.
Marshall Wace first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Marshall Wace's DICE Therapeutics, Inc. Common Stock position peaked at $5.37M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.